Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...

On February 9, 2010, the then Minister of Environment and Forests, Government of India, Jairam Ramesh, imposed an indefinite moratorium on the introduction of Bt Brinjal in India. It is necessary and desirable to quote the order verbatim. It reads as follows: It is my duty to adopt a cautious, precautionary based approach and impose a moratorium on the release of Bt Brinjals till such time independent scientific studies establish, to...

The government has taken exception to the `biases' in the United NationsDevelopment Programme's (UNDP) Asia Pacific Human Development report, titled, One Planet, which was released on Thursday. UNDP, required to play a neutral role in international governance, has recommended that India and other countries in the Asia Pacific region take greater responsibility to reduce emissions and warned that 'inclusive growth' would increase emissions, a trade-off that India cannot afford. Pointing...

Countries in Asia and the Pacific must strike a balance between rising prosperity and rising emission as their success or failure will have repercussions worldwide, a latest report of the United Nations Development Programme (UNDP) has said. "The Asia-Pacific region must continue to grow economically to lift millions out of poverty, but it must also respond to climate change to survive. Growing first and cleaning up later is no longer an...

-The Hindu Business Line The onus of granting approvals to medicines marketed in the country is on the regulator Drug Controller General of India (DCGI), say drug companies, adding that they have adhered to the law of the land. The drug-makers were responding to a Parliamentary panel report on health that severely indicted the drug regulatory authority, besides alleging that “invisible hands” of drug-makers were involved in getting favourable reports on medicines...